Illegal drugs worth Rs 80 lakhs confiscated


Acting on a tip off, Drug Controller, Mumbai and FDA Maharashtra confiscated illegal drugs worth 80 lakhs imported from China The drugs were imported illegally without drug registration and drug import licence under the Drugs and Cosmetics Act by Sarvodaya Enterprises and Sidhambika Pharma Pvt Ltd at Mumbai from unregistered sources in China.

Acting on a tip off, Drug Controller, Mumbai and FDA Maharashtra confiscated illegal drugs worth 80 lakhs imported from China The drugs were imported illegally without drug registration and drug import licence under the Drugs and Cosmetics Act by Sarvodaya Enterprises and Sidhambika Pharma Pvt Ltd at Mumbai from unregistered sources in China. Both firms having their Offices at two places viz., Princess Street, Vile Parle and Godown at Bhiwandi (same for both ). Simultaneous raids were conducted at all the three places on Monday, the 25th October, 2010 by Inspectors from CDSCO West Zone, Mumbai and FDA Maharashtra. Shri Devang Parekh was one of the Partners in both the firms. However, the office at Princess Street was occupied by some other party and not by the above firms.

The Drug Controller, West Zone, Mumbai has seized 1450 Kgs of Sulphadoxine BP/USP, 406 Kgs of Streptomycin Sulfate Sterile Bulk EP, 775 Kgs of Nitrofurantoin BP 2005 and 500 Kgs of Rutin NF-11, the approximate cost of the confiscated drugs is Rs. 80.00 Lacs.It is understood that all the consignments were released from the Customs, Air Cargo Complex, Sahar, Mumbai without referring them to the Office of the Assistant Drugs Controller (India), Air Cargo Complex, Sahar, Mumbai. The consignments were also released by the Customs with the connivance of Custom Examiners without insisting on producing the drug import licence/drug registration. It is understood that since April, the above firms cleared about 60 consignments of bulk drugs having value of several crores of rupees imported from unregistered sources in China from the Customs without insisting on drug import licence/drug registration. Further Investigations as to the end use will be carried out at manufacturers' level who have purchased the bulk drugs from the above importers, as Schedule M Part I (10.3) clearly states that the manufacturers should procure the drugs from approved sources onlyFurther investigations in the matter are under progress. The SIIB of Customs at Air Cargo Complex is also investigating the matter separately and it is understood that some of the Partners of the above firm's are already under Customs custody.


Comments

No responses found. Be the first to comment...


  • Do not include your name, "with regards" etc in the comment. Write detailed comment, relevant to the topic.
  • No HTML formatting and links to other web sites are allowed.
  • This is a strictly moderated site. Absolutely no spam allowed.
  • Name:
    Email: